Intravitreal injection of tissue plasminogen activator and gas bubble for treatment of subretinal hemorrhage in ARMD

Optometry

Volumn 71, Issue 11, 2000, Pages 715-721

  Hay, Shelly R ^a,b   Madonna, Richard J ^b  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

Age related macular degeneration; choroidal neovascularization; intravitreal gas; subretinal hemorrhage; tissue plasminogen activator

Indexed keywords

PLASMINOGEN ACTIVATOR; SULFUR HEXAFLUORIDE; TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; CASE REPORT; HUMAN; INJECTION; MALE; PATHOLOGY; RETINA; RETINA HEMORRHAGE; RETINA MACULA DEGENERATION; VISUAL ACUITY; VITREOUS BODY;

AGED; HUMANS; INJECTIONS; MACULAR DEGENERATION; MALE; PLASMINOGEN ACTIVATORS; RETINA; RETINAL HEMORRHAGE; SULFUR HEXAFLUORIDE; TISSUE PLASMINOGEN ACTIVATOR; VISUAL ACUITY; VITREOUS BODY;

EID: 0034320466     PISSN: 15291839     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (47)

1. Heriot WJ. Intravitreal gas and tPA: an outpatient procedure for submacular hemorrhage. Aust NZJ Ophthalmol (in press).
2. Hassan AS, Johnson MW, Schneiderman TE, et al. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement. Ophthalmology 1999;106:1900-7.
3. Hochman MA, Seery CM, Zarbin MA. Pathophysiology and management of subretinal hemorrhage. Surv Ophthalmology 1997;42:195-213.
4. Alexander LJ. Primary care of the posterior segment, 2nd ed. chap. 4. East Norwalk, Conn.: Appleton & Lange, 1994:
5. Miller JW, Adamis AP, Shima DT, et al. Vascular endothelial growth factor/ vascular permeability factor is temporally and spatially correlated with ocular angiogenesis in primate model. Am J Pathol 1994;145:574-84.
6. Morse LS, TerrellJ, Sidikaro Y. Bovine retinal pigment epithelium promotes proliferation of choroidal endothelium in vitro. Arch Ophthalmol 1989;107:1659-63.
7. Pierce EA, Avery RL, Foley ED, et al. Vascular endothelial growth factor/vascular permeability factor expression in mouse model of retinal neovascularization. Proc Natl Acad Sci USA 1995; 92:905-9.
8. Stone J, Itin A, Alon T, et al. Development of retinal vasculature is mediated by hypoxia induced vascular endothelial growth factor (VEGF) expression by neuroglia. J Neurosci 1995;15:4738-47.
9. Wong HC, Boulton M, McLeod D, et al. Retinal pigment epithelial cells in culture produce retinal vascular mitogens. Arch Ophthalmol 1988;106:1439-43.
10. Green WR, Enger C. Age-related macular degeneration histopathologic studies. The 1992 Lorenz E. Zimmerman lecture. Ophthalmology 1993;100:1519-35.
11. Ikuno Y, Lewis JM, Kamei M. Pearls in the management of submacular hematoma. Semin Ophthalmol 1998;13:40-51.
12. Lim JI. Subretinal hemorrhage. Int Ophthalmol Clin 1995; 35:95-104.
13. Bennett SR, Folk JC, Blodi CF, et al. Factors prognostic of visual outcome in patients with subretinal hemorrhage involving the fovea. Am J Ophthalmol 1990;109:33-7.
14. Berrocal MH, Lewis MI, Klynn HW. Variations in the clinical course of submacular hemorrhage. Am J Ophthalmol 1996;122:486-93.
15. Lewis H, Sloan SH, Foos RY. Massive intraocular hemorrhage associated with anticoagulation and age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 1988;226:59-64.
16. Johnson MW, Olsen KR, Hernandez E. Tissue plasminogen activator thrombolysis during surgical evacuation of experimental subretinal hemorrhage. Ophthalmology 1992;99:515-21.
17. Lim JI, Drews-Botsch C, Sternberg P, et al. Submacular hemorrhage removal. Ophthalmology 1995;102:1393-9.
18. Glatt H, Machemer R. Experimental subretinal hemorrhage in rabbits. Am J Ophthalmol 1982;94:762-73.
19. Toth CA, Morse LS, Hjelmeland LM, et al. Fibrin directs early retinal damage after experimental subretinal hemorrhage. Arch Ophthalmol 1991;109:723-9.
20. Avery RL, Fekrat S, Hawkins BS, et al. Natural history of subfoveal subretinal hemorrhage in age-related macular degeneration. Retina 1996;16:183-9.
21. Coll GE, Sparrow JR, Marinovic A, et al. Effect of intravitreal tissue plasminogen activator on experimental subretinal hemorrhage. Retina 1995;15:319-26.
22. Koshibu A. Ultrastructural studies on absorption of an experimentally produced subretinal hemorrhage III. Absorption of erythrocyte breakdown products and retinal hemosiderosis at the late stage. Act Soc Ophthalmol Jpn 1979;83:386-400.
23. Johnson MW, Olsen KR, Hernandez E, et al. Tissue plasminogen activator treatment of experimental subretinal hemoprrhage. Retina 1991;11:250-8.
24. Sanders D, Peyman GA, Fishman G, et al. The toxicity of whole blood and hemoglobin. Graefes Arch Clin Exp Ophthalmol 1975;197:255-67.
25. Hewitt AT, Adler R. The retinal pigment epithelium and interphotoreceptor matrix. Structure and specialized functions. In: Ryan SJ, ed. Retina, 2nd ed. St. Louis: Mosby, 1994:58-71.
26. Luxenberg MN. Early surgical drainage of macula subretinal hemorrhage. Arch Ophthalmol 1987;105:1722-3.
27. de Juan E Jr, Machemer R. Vitreous surgery for hemorrhage and fibrous complications of age-related macular degeneration. Am J Ophthalmol 1988;105:25-9.
28. Wade EC, Flynn HW Jr, Olsen KR, et al. Subretinal hemorrhage management by pars plana vitrectomy and internal drainage. Arch Ophthalmol 1990;108:973-8.
29. Vander JF, Federman JI, Greven C, et al. Surgical removal of massive subretinal hemorrhage associated with age-related macular degeneration. Ophthalmology 1991;98: 23-7.
30. Dellaporta AN. Evacuation of subretinal hemorrhage. Int Ophthalmol 1994;18:25-31.
31. Dellaporta AN. Retinal damage from subretinal hemorrhage. Am J Ophthalmol 1983;95:568-70.
32. Hanscom TA, Diddie KR. Early surgical drainage of macular subretinal hemorrhage. Arch Ophthalmol 1987;105: 1722-3.
33. Hayasaka S, Uchida M, Setogwa T. Subretinal hemorrhages with or without choroidal neovascularization on the maculas of patients with pathologic myopia. Graefes Arch Clin Exp Ophthalmol 1990;228:277-80.
34. Clarkson JG, Altman RD. Angiod streaks. Surv Ophthalmol 1982;26:235-46.
35. Hoylaerts M, Rijken DC, Lijnen HR, et al. Kinetics of the activation of plasminogen by human tissue plasminogen activator. Role of fibrin. J Biol Chem 1982;257:2912-9.
36. Peyman GA, Nelson NC Jr, Alturki W, et al. Tissue plasminogen activating factor assisted removal of subretinal hemorrhage. Ophthalmic Surg 1991;22:575-82.
37. Lewis H. Intraoperative fibrinolysis of submacular hemorrhage with tissue plasminogen activator and surgical drainage. Am J Ophthalmol 1994;118:559-68.
38. Johnson MW, Olsen KR, Hernandez E. Tissue plasminogen activator treatment of experimental subretinal hemorrhage. Retina 1991;11:250-8.
39. Kamei M, Tano Y, Maeno T, et al. Surgical removal of submacular hemorrhage using tissue plasminogen activator and perfluorocarbon liquid. Am J Ophthalmol 1996; 121:267-75.
40. Saika S, Yamanaka A, Yamanaka A, et al. Subretinal administration of tissue-type plasminogen activator to speed the drainage of subretinal hemorrhage. Graefes Arch Clin Exp Ophthalmol 1998;236:196-201.
41. Vander JF. Tissue plasminogen activator. Irrigation to facilitate removal of subretinal hemorrhage during vitrectomy. Ophthalmic Surg 1992;23:361-3.
42. Moriarty AP, McAllister IL, Constable IJ. Initial clinical experience with tissue plasminogen activator (tPA) assisted removal of submacular haemorrhage. Eye 1995; 9:582-8.
43. Hesse L, Kroll P. Successful treatment of acute subretinal hemorrhage in age-related macular degeneration by combined intravitreal injection of recombinant tissue plasminogen activator and gas. Adv Ther 1997;14:275-80.
44. Hesse L, Schmidt J, Kroll P. Management of acute submacular hemorrhage using recombinant tissue plasminogen activator and gas. Graefes Arch Clin Exp Ophthalmol 1999;237:273-7.
45. Macular Photocoagulation Study Group: Subfoveal neovascular lesions in age-related macular degeneration: guidelines for evaluation and treatment in the Macular Photocoagulation Study. Arch Ophthalmol 1991;109:1242-57.
46. Macular Photocoagulation Study Group: Laser photocoagulation of subfoveal neovascular lesions of age-related macular degeneration: updated findings from two clinical trials. Arch Opthalmol 1993;111:1200-9.
47. Macular Photocoagulation Study Group: Visual outcome after laser photocoagulation for subfoveal choroidal neovascularization secondary to age-related macular degeneration: the influence of initial lesion size and initial visual acuity. Arch Ophthalmol 1994;112:480-8.